Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Inflammatory Bowel Diseases

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Inflammatory Bowel Diseases in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oshima, T1
Jordan, P1
Grisham, MB2
Alexander, JS1
Jennings, M1
Sasaki, M1
Manas, K1
Krieglstein, CF1
Cerwinka, WH1
Laroux, FS1
Salter, JW1
Russell, JM1
Schuermann, G1
Ross, CR1
Granger, DN1

Other Studies

2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Inflammatory Bowel Diseases

ArticleYear
TNF-alpha induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide.
    BMC gastroenterology, 2001, Volume: 1

    Topics: Amidines; Animals; Benzylamines; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Adhesion Molecules;

2001
Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide.
    The Journal of experimental medicine, 2001, Nov-05, Volume: 194, Issue:9

    Topics: Amidines; Animals; Benzylamines; Colitis, Ulcerative; Colon; Dextran Sulfate; Digestive System; Dige

2001